ArticleCPT: pharmacometrics & systems pharmacology2025

A Multiple-Model-Informed Drug-Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab.

Akihiro Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.